Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > 14 to go?, 13?, 12?…
View:
Post by mercedesman on Sep 30, 2024 9:06am

14 to go?, 13?, 12?…

From Sept 3 release re: August stats ....


"With 21 patients to full enrollment, the Company has entered the final push to fully enroll and finish the Tigris trial
  • Based on current rate of enrollment, Tigris could be completed as early as December 2024

Dr. John Kellum, Chief Medical Officer of Spectral, noted, “It's gratifying to see that despite August vacation schedules, enrollment continues to be strong. We continue to enjoy very strong activity at our sites. As such, we remain confident in finalizing full Tigris enrollment around year end 2024.

With the Sept stat release due this week, the home stretch is finally upon us. 

And just in time for:
 

  • Eden study results
  • Baxter CG transaction closing on Vantive
  • Prismax pump approval for use in HP across US 
  • CG's tire kicking review of Spectral? ( ie will they unveil a plan to be only in the competitive US dialysis business, or perhaps alternatively, a plan to be in the business of innovative  precision medicine with a global reach, backed by multiple FDA approvals  ?) 
MM
Comment by TechOne on Sep 30, 2024 12:42pm
We should get an update for September numbers tomorrow or may be day after..  Let's see if Vacation slow down is over or not..  But we are on home stretch any ways..  Just wish share price is at least over a $ 1 ..  For god sake.. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities